Publicaciones en las que colabora con Jerónimo Pachón Díaz (52)

2024

  1. Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of Escherichia coli and Acinetobacter baumannii

    Antibiotics, Vol. 13, Núm. 5

2023

  1. Analysis of bacterial pangenomes reduces CRISPR dark matter and reveals strong association between membranome and CRISPR-Cas systems

    Science advances, Vol. 9, Núm. 12, pp. eadd8911

  2. Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection

    Journal of Infection, Vol. 87, Núm. 3, pp. 220-229

2021

  1. AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections

    Frontiers in Microbiology, Vol. 12

  2. Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models

    Antibiotics, Vol. 10, Núm. 2, pp. 1-8

  3. Impact of the COVID-19 Pandemic on Survival in the Patients With the Intra-Abdominal Infections

    Frontiers in Medicine, Vol. 8

  4. Potential tamoxifen repurposing to combat infections by multidrug-resistant gram-negative Bacilli

    Pharmaceuticals, Vol. 14, Núm. 6

  5. Repurposing of the tamoxifen metabolites to combat infections by multidrug-resistant gram-negative bacilli

    Antibiotics, Vol. 10, Núm. 3

  6. Repurposing of the tamoxifen metabolites to treat methicillin-resistant staphylococcus epidermidis and vancomycin-resistant enterococcus faecalis infections

    Microbiology Spectrum, Vol. 9, Núm. 2

  7. Semirapid detection of piperacillin/tazobactam resistance and extended-spectrum resistance to b-lactams/b-lactamase inhibitors in clinical isolates of escherichia coli

    Microbiology Spectrum, Vol. 9, Núm. 2

2020

  1. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 77-85

  2. In silico discovery of Acinetobacter baumannii genes involved in microaerobiosis resistance

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9

  3. In vitro effect of ceftazidime-avibactam pressure on ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae clinical isolates

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 9

  4. Repositioning rafoxanide to treat Gram-negative bacilli infections

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 7, pp. 1895-1905

  5. Role of PstS in the pathogenesis of acinetobacter baumannii under microaerobiosis and normoxia

    Journal of Infectious Diseases, Vol. 222, Núm. 7, pp. 1204-1212

  6. Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii

    Virulence, Vol. 11, Núm. 1, pp. 1727-1737

2019

  1. Pangenome of acinetobacter baumannii uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation

    Microbial Genomics, Vol. 5, Núm. 11

  2. Phylogeny, resistome, and virulome of escherichia coli causing biliary tract infections

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  3. Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients

    BMC Infectious Diseases, Vol. 19, Núm. 1

  4. Relationship between different resistance mechanisms and virulence in acinetobacter baumannii

    Microbial Drug Resistance, Vol. 25, Núm. 5, pp. 752-760